In this exclusive Urology Times interview, Joseph W. Segura, MD, discussesthe current state and the future of AUA clinical practice guidelines, includinghow guidelines influence practice, their use in residency training, andupcoming guideline topics. Dr. Segura is the Carl Rosen professor of urologyat Mayo Medical School, Rochester, MN, and chairman of AUA's Practice GuidelinesCommittee. The interview was conducted by UT editorial consultant PhilipM. Hanno, MD, of the department of urology, University of Pennsylvania,Philadelphia.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.